BCLI – Brainstorm Cell Therapeutics, Inc.
Name :
Sector :
Industry:
Mark. Cap: $0.0000
EPSttm :
Float Short %
2.11
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
1.8
EPS Last/This Y
3.9
EPS This/Next Y
0.51
Price
1.89
Target Price
10
Analyst Recom
1
Performance Q
-13.3
Relative Volume
0.7
Beta
0.27
Ticker: BCLI
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2024-12-19 | BCLI | 2.03 | 0.02 | 0.00 | 787 |
| 2024-12-20 | BCLI | 2.26 | 0.02 | 0.00 | 787 |
| 2024-12-23 | BCLI | 2.05 | 0.02 | 0.00 | 787 |
| 2024-12-24 | BCLI | 2.23 | 0.02 | 0.00 | 787 |
| 2024-12-26 | BCLI | 2.5 | N/A | N/A | 0 |
| 2024-12-27 | BCLI | 2.44 | 0.02 | 0.00 | 789 |
| 2024-12-30 | BCLI | 2.36 | 0.02 | 0.00 | 849 |
| 2024-12-31 | BCLI | 2.27 | 0.02 | 0.00 | 849 |
| 2025-01-02 | BCLI | 2.14 | 0.02 | 0.00 | 849 |
| 2025-01-03 | BCLI | 2.21 | 0.02 | 0.00 | 849 |
| 2025-01-06 | BCLI | 2.27 | 0.02 | 0.00 | 849 |
| 2025-01-07 | BCLI | 2.22 | N/A | N/A | 0 |
| 2025-01-08 | BCLI | 2.07 | N/A | N/A | 0 |
| 2025-01-09 | BCLI | 2.09 | N/A | N/A | 0 |
| 2025-01-10 | BCLI | 2.01 | N/A | N/A | 0 |
| 2025-01-13 | BCLI | 1.98 | N/A | N/A | 0 |
| 2025-01-14 | BCLI | 2.07 | N/A | N/A | 0 |
| 2025-01-15 | BCLI | 2.09 | N/A | N/A | 0 |
| 2025-01-16 | BCLI | 1.99 | N/A | N/A | 0 |
| 2025-01-17 | BCLI | 1.88 | N/A | N/A | 0 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2024-12-19 | BCLI | 2.03 | 81.3 | - | -2.31 |
| 2024-12-20 | BCLI | 2.27 | 81.3 | - | -2.10 |
| 2024-12-23 | BCLI | 2.07 | 82.0 | - | -2.10 |
| 2024-12-24 | BCLI | 2.23 | 82.0 | - | -2.10 |
| 2024-12-26 | BCLI | 2.48 | 82.0 | - | -2.10 |
| 2024-12-27 | BCLI | 2.45 | 82.0 | - | -2.10 |
| 2024-12-30 | BCLI | 2.39 | 82.0 | - | -2.10 |
| 2024-12-31 | BCLI | 2.27 | 82.0 | - | -2.10 |
| 2025-01-02 | BCLI | 2.14 | 82.0 | - | -2.10 |
| 2025-01-03 | BCLI | 2.23 | 82.0 | - | -2.10 |
| 2025-01-06 | BCLI | 2.29 | 82.0 | - | -2.10 |
| 2025-01-07 | BCLI | 2.23 | 82.0 | - | -2.10 |
| 2025-01-08 | BCLI | 2.09 | 82.0 | - | -2.10 |
| 2025-01-09 | BCLI | 2.09 | 82.0 | - | -2.10 |
| 2025-01-10 | BCLI | 2.02 | 82.0 | - | -2.10 |
| 2025-01-13 | BCLI | 2.02 | 82.0 | - | -2.10 |
| 2025-01-14 | BCLI | 2.06 | 82.0 | - | -2.10 |
| 2025-01-15 | BCLI | 2.05 | 82.0 | - | -2.10 |
| 2025-01-16 | BCLI | 2.01 | 82.0 | - | -2.10 |
| 2025-01-17 | BCLI | 1.89 | 82.0 | - | -2.10 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2024-12-19 | BCLI | -4.89 | -2.50 | 3.00 |
| 2024-12-20 | BCLI | -4.89 | -2.50 | 3.00 |
| 2024-12-23 | BCLI | -4.48 | -2.60 | 3.00 |
| 2024-12-24 | BCLI | -4.48 | -2.60 | 3.00 |
| 2024-12-26 | BCLI | -4.55 | -2.60 | 3.08 |
| 2024-12-27 | BCLI | -4.89 | -2.60 | 3.08 |
| 2024-12-30 | BCLI | -4.95 | -2.60 | 3.08 |
| 2024-12-31 | BCLI | -4.95 | -2.60 | 3.08 |
| 2025-01-02 | BCLI | -5.09 | -2.60 | 3.08 |
| 2025-01-03 | BCLI | -4.89 | -2.60 | 3.08 |
| 2025-01-06 | BCLI | -4.70 | -2.60 | 3.08 |
| 2025-01-07 | BCLI | -4.70 | -2.60 | 3.08 |
| 2025-01-08 | BCLI | -4.89 | -2.60 | 3.08 |
| 2025-01-09 | BCLI | -3.15 | -2.60 | 3.39 |
| 2025-01-10 | BCLI | -3.15 | -2.60 | 3.39 |
| 2025-01-13 | BCLI | -2.98 | -2.60 | 2.11 |
| 2025-01-14 | BCLI | -2.98 | -2.60 | 2.11 |
| 2025-01-15 | BCLI | -2.98 | -2.60 | 2.11 |
| 2025-01-16 | BCLI | -2.99 | -2.60 | 2.11 |
| 2025-01-17 | BCLI | -2.99 | -2.60 | 2.11 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.8
Avg. EPS Est. Current Quarter
-0.27
Avg. EPS Est. Next Quarter
Insider Transactions
-2.99
Institutional Transactions
-2.6
Beta
0.27
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
35
Growth Score
21
Sentiment Score
42
Actual DrawDown %
99.3
Max Drawdown 5-Year %
-99.6
Target Price
10
P/E
Forward P/E
PEG
P/S
P/B
P/Free Cash Flow
EPS
-3.49
Average EPS Est. Cur. Y
-2.1
EPS Next Y. (Est.)
-1.59
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.7
Return on Equity vs Sector %
215.8
Return on Equity vs Industry %
228.4
EPS 1 7Days Diff
0.2
EPS 1 30Days Diff
0.21
EBIT Estimation
stock quote shares BCLI – Brainstorm Cell Therapeutics, Inc. Stock Price stock today
news today BCLI – Brainstorm Cell Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch BCLI – Brainstorm Cell Therapeutics, Inc. yahoo finance google finance
stock history BCLI – Brainstorm Cell Therapeutics, Inc. invest stock market
stock prices BCLI premarket after hours
ticker BCLI fair value insiders trading